Clinical Trial Update: Combined Radiotherapy and Sorafenib in Patients With Hepatoma

View source ↗

Summary

This clinical trial update discusses combining radiotherapy with sorafenib for hepatocellular carcinoma. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Nexavar (Sorafenib)

Snippet

Sponsor: China Medical University Hospital | Conditions: Hepatocellular Carcinoma | Status: UNKNOWN